评估影响药剂师和药房技术人员对在沙特阿拉伯从事CE活动的满意度的因素
Raniah Aljadeed1, Rana Aljadeed1, Wasmeah Alsamti2
1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
概括
沙特阿拉伯的药剂师和技术人员报告说,由于工作限制和安排,他们对继续教育 (CE) 的满意度很低. 提高CE质量和可访问性需要利益相关方的合作伙伴关系,以满足从业者的偏好.
科学领域:
- 药房实践 在药房实践中
- 继续教育继续教育.
- 医疗保健专业发展
背景情况:
- 继续教育 (CE) 对于药房专业人员来说至关重要,以保持最新的知识和技能.
- 监管任务需要药剂师和技术人员的持续专业发展.
- 评估对当前CE实践的满意度对于专业成长至关重要.
研究的目的:
- 评估影响沙特阿拉伯药剂师和药房技术人员对CE实践满意度水平的因素.
- 确定影响参与CE活动的关键障碍和促进因素.
- 了解药房专业人员对CE格式和内容的偏好.
主要方法:
- 一个自我管理的调查被开发和分发给沙特阿拉伯的药剂师和药房技术人员.
- 该调查包括关于人口统计,CE活动,整体满意度和障碍/促进者的部分,使用5分利克尔特等级.
- 在2018年1月至2019年2月期间,从398名药剂师和40名药房技术人员收集了数据.
主要成果:
- 只有四分之一的参与者表示对当前的CE实践感到满意.
- 最主要的障碍包括工作限制,成本,安排,缺乏信息和职业倦怠.
- 与他们的同行相比,药房技术人员和沙特药剂师报告了明显更高的不满和更多的障碍.
- 促进者包括学习的愿望,许可要求,放松和网络机会.
- 参与者更喜欢会议,互动研讨会,简短的会议和疾病/药物管理主题.
结论:
- 在沙特阿拉伯,有很大需要提高CE课程的质量和可访问性.
- 涉及利益相关者的协作战略对于改善CE至关重要.
- CE计划的设计应与药房从业人员的偏好和实际需求保持一致.
相关概念视频
Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
1.7K
Evaluation of the teaching process enables the nurse to determine if the patient's learning needs were met and if training was effective. If the expected outcomes are not met, the care plan is revised, and additional education or reinforcement is provided. Nurses can ask questions after the session or obtain feedback to assess the patient's understanding of the topic.
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
1.7K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
129
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
129
Structure-Activity Relationships and Drug Design
699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
198
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
198
Nursing Evaluation
3.3K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.3K
Pharmacovigilance
825
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
825


